A comprehensive view of Inflammations. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Almirall acquires global rights to develop and market Novo Nordisk's IL-21 blocking monoclonal antibody, NN-8828, for immune inflammatory dermatological diseases; Almirall to explore the new approach of IL-21 blockage as a treatment for skin disorders

Sanofi's Dupixent and rilzabrutinib treatments show promise in improving lung function and providing relief for inflammatory diseases such as moderate-to-severe asthma and eosinophilic esophagitis; data presented at the AAAAI Annual Meeting

GSK enters agreement to acquire Aiolos Bio, a clinical-stage biopharmaceutical company focused on unmet needs for respiratory and inflammatory conditions; transaction includes US$1B upfront payment and up to US$400M in milestone-related payments

IMIDomics expands strategic collaboration with Bristol Myers Squibb to advance research and development for immune-mediated inflammatory diseases; collaboration now including Sjögren's disease and atopic dermatitis

Century Therapeutics and FUJIFILM Cellular Dynamics have expanded their existing agreement to develop cell therapies from induced pluripotent stem cells for the treatment of autoimmune and inflammatory diseases

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count